Zacks Research Comments on Maximus, Inc.’s Q2 2024 Earnings (NYSE:MMS)

Maximus, Inc. (NYSE:MMSFree Report) – Investment analysts at Zacks Research upped their Q2 2024 earnings per share estimates for shares of Maximus in a research report issued on Tuesday, April 23rd. Zacks Research analyst R. Department now forecasts that the health services provider will post earnings of $1.33 per share for the quarter, up from their prior estimate of $1.31. The consensus estimate for Maximus’ current full-year earnings is $5.41 per share. Zacks Research also issued estimates for Maximus’ Q4 2024 earnings at $1.38 EPS, FY2024 earnings at $5.39 EPS, Q3 2025 earnings at $1.35 EPS, Q4 2025 earnings at $1.42 EPS and Q2 2026 earnings at $1.06 EPS.

Maximus (NYSE:MMSGet Free Report) last posted its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.06. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The company had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.29 billion. During the same period in the previous year, the firm earned $0.94 EPS. The firm’s revenue was up 6.2% compared to the same quarter last year.

MMS has been the topic of a number of other research reports. StockNews.com raised Maximus from a “hold” rating to a “buy” rating in a research note on Thursday, February 8th. Raymond James downgraded Maximus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 3rd.

Check Out Our Latest Analysis on MMS

Maximus Stock Performance

NYSE:MMS opened at $80.98 on Wednesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69. Maximus has a 1 year low of $72.39 and a 1 year high of $89.69. The stock’s 50 day simple moving average is $82.64 and its two-hundred day simple moving average is $81.26. The company has a market cap of $4.94 billion, a price-to-earnings ratio of 26.81 and a beta of 0.72.

Institutional Trading of Maximus

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Louisiana State Employees Retirement System increased its stake in Maximus by 2.9% in the first quarter. Louisiana State Employees Retirement System now owns 17,600 shares of the health services provider’s stock worth $1,477,000 after purchasing an additional 500 shares during the period. New Century Financial Group LLC bought a new position in shares of Maximus during the 1st quarter worth $1,069,000. State of Michigan Retirement System grew its position in shares of Maximus by 2.7% during the 1st quarter. State of Michigan Retirement System now owns 15,018 shares of the health services provider’s stock worth $1,260,000 after buying an additional 400 shares in the last quarter. Allspring Global Investments Holdings LLC grew its position in shares of Maximus by 0.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 705,302 shares of the health services provider’s stock worth $59,175,000 after buying an additional 3,680 shares in the last quarter. Finally, Chatham Capital Group Inc. grew its position in shares of Maximus by 12.9% during the 1st quarter. Chatham Capital Group Inc. now owns 35,519 shares of the health services provider’s stock worth $2,980,000 after buying an additional 4,050 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Insider Activity

In other news, CFO David Mutryn sold 8,000 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $83.95, for a total transaction of $671,600.00. Following the transaction, the chief financial officer now owns 5,124 shares of the company’s stock, valued at approximately $430,159.80. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.40% of the company’s stock.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.48%. The ex-dividend date of this dividend is Tuesday, May 14th. Maximus’s dividend payout ratio is currently 39.74%.

Maximus Company Profile

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Earnings History and Estimates for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.